DE69113871T2 - Hypotriglyceridämische Verwendung von Bis(3,5-di-alkyl-4-hydroxyphenylthio)methanen. - Google Patents

Hypotriglyceridämische Verwendung von Bis(3,5-di-alkyl-4-hydroxyphenylthio)methanen.

Info

Publication number
DE69113871T2
DE69113871T2 DE69113871T DE69113871T DE69113871T2 DE 69113871 T2 DE69113871 T2 DE 69113871T2 DE 69113871 T DE69113871 T DE 69113871T DE 69113871 T DE69113871 T DE 69113871T DE 69113871 T2 DE69113871 T2 DE 69113871T2
Authority
DE
Germany
Prior art keywords
hypertriglyceridemia
hydroxyphenylthio
bis
compound
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69113871T
Other languages
German (de)
English (en)
Other versions
DE69113871D1 (de
Inventor
Richard L Jackson
George Ku
Simon J T Mao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69113871D1 publication Critical patent/DE69113871D1/de
Publication of DE69113871T2 publication Critical patent/DE69113871T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69113871T 1990-06-19 1991-06-18 Hypotriglyceridämische Verwendung von Bis(3,5-di-alkyl-4-hydroxyphenylthio)methanen. Expired - Fee Related DE69113871T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/540,657 US5122542A (en) 1990-06-19 1990-06-19 Hypotriglyceridemic use of certain bis (3,5-di-alkyl-4-hydroxyphenylthio)methanes

Publications (2)

Publication Number Publication Date
DE69113871D1 DE69113871D1 (de) 1995-11-23
DE69113871T2 true DE69113871T2 (de) 1996-04-04

Family

ID=24156398

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69113871T Expired - Fee Related DE69113871T2 (de) 1990-06-19 1991-06-18 Hypotriglyceridämische Verwendung von Bis(3,5-di-alkyl-4-hydroxyphenylthio)methanen.

Country Status (13)

Country Link
US (1) US5122542A (enExample)
EP (1) EP0462556B1 (enExample)
JP (1) JPH04230213A (enExample)
KR (1) KR0168649B1 (enExample)
AT (1) ATE129151T1 (enExample)
AU (1) AU640486B2 (enExample)
DE (1) DE69113871T2 (enExample)
DK (1) DK0462556T3 (enExample)
ES (1) ES2080854T3 (enExample)
GR (1) GR3018351T3 (enExample)
IE (1) IE69315B1 (enExample)
TW (1) TW205542B (enExample)
ZA (1) ZA914538B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100004333A1 (en) * 2004-12-17 2010-01-07 Stocker Roland O Compositions and methods for treating cardiovascular disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734527A (en) * 1986-10-17 1988-03-29 Merrell Dow Pharmaceuticals Inc. Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol
US4900757A (en) * 1988-12-08 1990-02-13 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane
US4954528A (en) * 1988-12-08 1990-09-04 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic use of bis(3,5-di-tertiary-butly-4-hydroxyphenylthio)methane
US4959392A (en) * 1989-07-24 1990-09-25 Merrell Dow Pharmaceuticals Inc. Method of treating diabetes mellitus

Also Published As

Publication number Publication date
IE69315B1 (en) 1996-09-04
AU7836591A (en) 1992-01-02
EP0462556A3 (en) 1992-03-11
TW205542B (enExample) 1993-05-11
GR3018351T3 (en) 1996-03-31
AU640486B2 (en) 1993-08-26
KR920000327A (ko) 1992-01-29
KR0168649B1 (ko) 1999-01-15
JPH04230213A (ja) 1992-08-19
EP0462556A2 (en) 1991-12-27
EP0462556B1 (en) 1995-10-18
ZA914538B (en) 1992-03-25
US5122542A (en) 1992-06-16
DK0462556T3 (da) 1995-11-27
ATE129151T1 (de) 1995-11-15
ES2080854T3 (es) 1996-02-16
IE912087A1 (en) 1992-01-01
DE69113871D1 (de) 1995-11-23

Similar Documents

Publication Publication Date Title
DE68903215T2 (de) Hypocholesterolaemische und antiatherosklerotische verwendung von bis-(3,5-di-tertiaerbutyl-4-hydroxyphenylthio)methan.
Bernsen et al. Treatment of complex I deficiency with riboflavin
DE69829966T2 (de) Ein monoether von probucol und methoden zur hemmung der vcam-1 expression
MESSINGER et al. Effect of feeding egg yolk and cholesterol on serum cholesterol levels
FR2555050A1 (fr) Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine, utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
DE69434720T2 (de) Verwendung von 2,6-Dialkyl-4-Silyl-Phenol Derivaten zur Behandlung von Xanthom
US4229439A (en) Method of treatment of atheroma
DE69016866T2 (de) Verwendung von Bis(4-hydroxyphenylthio)methan-Derivaten zur Behandlung von Diabetes mellitus.
EP0319288B1 (en) dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent
DE69526731T2 (de) Hypocholesterolämische,antiatherosklerotische und hypotriglyceridämische mercaptoacetylamid-derivate
Van Hellenberg Hubar et al. MELAS Syndrome-Report of Two Patients, and Comparison with Data of 24 Patients Derived from the Literature
AU610611B2 (en) Use of c-5 mono-substituted barbiturates to treat disorders of uric acid metabolism
DE69214180T2 (de) Verwendung von Bis-(p-Hydroxyphenylthio)methanderivaten zur Hemmung der fortschreitenden Entwicklung von insulinabhängingem Diabetes mellitus
KR0168649B1 (ko) 비스(3,5-디-알킬-4-히드록시페닐티오)메탄을 유효 성분으로 함유하는 고트리글리세리드혈증 치료용 제약 조성물
DE69021664T2 (de) Verwendung von bisphenol-Derivaten zur Behandlung von Diabetes mellitus.
EP0087744B1 (en) Lipid metabolism improving agents
US4954528A (en) Hypocholesterolemic use of bis(3,5-di-tertiary-butly-4-hydroxyphenylthio)methane
DE69531489T2 (de) Cholesterin senkende mercaptoacetylamiddisulfidderivate
Eisenberg Type III hyperlipoproteinaemia
US4151281A (en) Medicinal preparation for the treatment of collagenoses of a rheumatoid nature
AT390880B (de) Pharmazeutische verwendung einer 8-chlorobenzothiazepinverbindung
FR2602143A1 (fr) Utilisation du diethylaminoethyldextran pour la fabrication d'un medicament destine a reduire l'hyperglycemie
DE3016520A1 (de) Verfahren zur verbesserung der bindungsfaehigkeit fuer cholesterin von (alpha)-lipoproteinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee